Morphic Therapeutic, a Waltham biotech startup, will receive $100 million from a licensing deal with Illinois-based drug maker AbbVie Inc. to develop medicines to treat fibrosis-related diseases.http://bos.gl/fQQgOPm
0 replies
3 retweets
9 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.